Premium
The excretion of 5‐oxoproline in urine, as an index of glycine status, during normal pregnancy
Author(s) -
PERSAUD C.,
McDERMOTT J.,
BENOIST B.,
JACKSON A. A.
Publication year - 1989
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1989.tb02420.x
Subject(s) - pregnancy , excretion , urine , creatinine , urinary system , medicine , third trimester , glycine , obstetrics , first trimester , physiology , endocrinology , fetus , biology , amino acid , biochemistry , genetics
Summary The urinary excretion of 5‐oxoproline, which may be used as an index of glycine status, was investigated in 30 normal pregnant women during different stages of pregnancy and in 18 non‐pregnant female volunteers. During an 18‐h study there was little variation in the 5‐oxoproline/creatinine index, and a single sample gave a representative value. The excretion of 5‐oxoproline/creatinine (μmol/mmol) rose progressively as pregnancy advanced (non‐pregnant mean 10, SD5, first trimester mean 46, SD 12, second trimester mean 150, SD 180, and third trimester mean 280, SD 320) and by the third trimester was over 20 times greater than in non‐pregnant women. The data suggest that as pregnancy advances the endogenous production of glycine may be insufficient to satisfy the increasing demands.